Documents and quality
Match each document to its purpose
Initial technical information supports screening. Actual supply requires the documents approved for the selected specification and batch.
| Document | Current purpose | Next step |
|---|---|---|
| Candidate briefs | Existing initial-review information | Choose a source below |
| Technical-evaluation TDS | Initial technical review, not released commercial limits | Request the relevant version |
| SDS and actual-batch COA | Approved safety and batch documents required before supply | Confirm with QA for the selected specification and lot |
| Storage and transport instructions | Approved conditions for the actual shipment | Confirm evidence, packaging and destination route before dispatch |
Company quality-system certificate
View the existing ISO 9001 certificate
The certificate states validity through 1 June 2029, subject to surveillance. Its technical-R&D scope is not ISO 22716, a product approval, an efficacy result or a sterile-product release claim.
INCI naming
INCI naming applications have been submitted. Results are expected in late November 2026, subject to review; neither the date nor the outcome is guaranteed. Naming does not establish ingredient safety or destination-market authorization.
Evidence boundaries
Particle counts and size do not alone establish EV purity or activity. Existing multi-ingredient finished-product reports cannot be treated as raw-material compatibility, stability or efficacy results. Initial review is non-clinical formulation evaluation, not testing on people. These preparations are not offered for injection or therapeutic use.
Discuss the documents you need